These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9077536)

  • 1. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients.
    Niwa T; Katsuzaki T; Miyazaki S; Miyazaki T; Ishizaki Y; Hayase F; Tatemichi N; Takei Y
    J Clin Invest; 1997 Mar; 99(6):1272-80. PubMed ID: 9077536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of imidazolone and N(epsilon)-(carboxymethyl)lysine in aortas of hemodialysis patients.
    Takayama F; Aoyama I; Tsukushi S; Miyazaki T; Miyazaki S; Morita T; Hirasawa Y; Shimokata K; Niwa T
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1101-9. PubMed ID: 9846892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin-induced diabetes.
    Niwa T; Katsuzaki T; Ishizaki Y; Hayase F; Miyazaki T; Uematsu T; Tatemichi N; Takei Y
    FEBS Lett; 1997 May; 407(3):297-302. PubMed ID: 9175872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway.
    Tsukushi S; Katsuzaki T; Aoyama I; Takayama F; Miyazaki T; Shimokata K; Niwa T
    Kidney Int; 1999 May; 55(5):1970-6. PubMed ID: 10231461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nepsilon-(Carboxymethyl)lysine and 3-DG-imidazolone are major AGE structures in protein modification by 3-deoxyglucosone.
    Jono T; Nagai R; Lin X; Ahmed N; Thornalley PJ; Takeya M; Horiuchi S
    J Biochem; 2004 Sep; 136(3):351-8. PubMed ID: 15598892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N2-carboxyethyl-2'-deoxyguanosine, a DNA glycation marker, in kidneys and aortas of diabetic and uremic patients.
    Li H; Nakamura S; Miyazaki S; Morita T; Suzuki M; Pischetsrieder M; Niwa T
    Kidney Int; 2006 Jan; 69(2):388-92. PubMed ID: 16408131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative quantification of N(epsilon)-(Carboxymethyl)lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry.
    Kislinger T; Humeny A; Peich CC; Zhang X; Niwa T; Pischetsrieder M; Becker CM
    J Agric Food Chem; 2003 Jan; 51(1):51-7. PubMed ID: 12502384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridoxal phosphate prevents progression of diabetic nephropathy.
    Nakamura S; Li H; Adijiang A; Pischetsrieder M; Niwa T
    Nephrol Dial Transplant; 2007 Aug; 22(8):2165-74. PubMed ID: 17449494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy.
    Zhou H; Tan KC; Shiu SW; Wong Y
    Nephrol Dial Transplant; 2008 Mar; 23(3):927-33. PubMed ID: 18065800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R; Balasubramanyam M; Rema M; Premanand C; Mohan V
    Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
    Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis.
    Niwa T; Katsuzaki T; Miyazaki S; Momoi T; Akiba T; Miyazaki T; Nokura K; Hayase F; Tatemichi N; Takei Y
    Kidney Int; 1997 Jan; 51(1):187-94. PubMed ID: 8995733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis.
    Fragedaki E; Nebel M; Schupp N; Sebekova K; Völkel W; Klassen A; Pischetsrieder M; Frischmann M; Niwa T; Vienken J; Heidland A; Stopper H
    Nephrol Dial Transplant; 2005 Sep; 20(9):1936-43. PubMed ID: 15919695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.
    Tanimoto M; Gohda T; Kaneko S; Hagiwara S; Murakoshi M; Aoki T; Yamada K; Ito T; Matsumoto M; Horikoshi S; Tomino Y
    Metabolism; 2007 Feb; 56(2):160-7. PubMed ID: 17224327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum.
    Niwa T; Takeda N; Yoshizumi H; Tatematsu A; Ohara M; Tomiyama S; Niimura K
    Biochem Biophys Res Commun; 1993 Oct; 196(2):837-43. PubMed ID: 8240359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
    Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
    J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients.
    Zhang X; Frischmann M; Kientsch-Engel R; Steinmann K; Stopper H; Niwa T; Pischetsrieder M
    Clin Chem Lab Med; 2005; 43(5):503-11. PubMed ID: 15899672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats.
    Boor P; Celec P; Behuliak M; Grancic P; Kebis A; Kukan M; Pronayová N; Liptaj T; Ostendorf T; Sebeková K
    Metabolism; 2009 Nov; 58(11):1669-77. PubMed ID: 19608208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.
    Kume S; Takeya M; Mori T; Araki N; Suzuki H; Horiuchi S; Kodama T; Miyauchi Y; Takahashi K
    Am J Pathol; 1995 Sep; 147(3):654-67. PubMed ID: 7545874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.